Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase shift in adult ADHD of sleep and appetite
2012-000320-18Phase 4Completed
- Sponsor
- Parnassia Groep
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of melatonin in delayed sleep-wake phase disorder (DSPD) and attention deficit hyperactivity disorder (ADHD), sponsored by Parnassia Groep. Primary endpoint: Phase advance of DLMO. Started Sep 2012; status: completed.
02
Drugs
melatonin
03
Conditions
delayed sleep-wake phase disorder (DSPD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2012-000320-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000320-18.